BRANDT KEVIN D (VP & Chief Commercial Officer) purchased 5.4% of their position (41.67K shares) of XTANT MEDICAL HOLDINGS, INC. on the open market
Open‑market purchase worth $49.8K — a moderate purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 11/17/2023ACC: 0001235802-23-000112
Officer· VP & Chief Commercial Officer
Since Jul 2018
+41.67K
Net shares
Net buyer
$49.8K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
41.67K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+41.67K
Price / share
$1.20
Trade value
$49.84K
% of position
5.4%
11/17/2023
774.19K→815.86K
Total
Net shares
+41.67K
Net value
$49.84K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/17/2023 | P · Purchase | +41.67K | $1.20 | $49.84K | 5.4% | 774.19K | 815.86K |
| Total | +41.67K | $49.84K | ||||||
Derivative Transactions0
No derivative transactions reported